|
 |
MenactraThis page contains recent news articles, when available, and an overview of Menactra but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Higher rates of Guillain-Barré have been associated with the swine flu vaccine and possibly with the meningitis vaccine Menactra, but it is no more common U.S. News & World Report, Adolescent health care subject at Rotary - 03 Jul 2008 The immunizations Lucas said were important for teenagers to receive were for Hepatitis A, Varicella, Menactra and Gardasil. Hepatitis A is a viral illness Ennis Daily News, Sanofi Expects Vaccine Sales Spike And Plans to Expand Its Production - Jun 25, 2008 The US factory will produce Menactra, a vaccine that prevents four types of bacterial meningitis. Sanofi charges about $82 per dose for the vaccine, Wall Street Journal Required Vaccines for 2008-2009 - Jun 26, 2008 The Menactra and TDAP vaccinations are required for those entering middle school for the 2008-2009 school year. Menactra fights against meningitis while the KFYR-TV, Baseball Bats, Bunk Beds and Sunscreen - Jun 9, 2008 The Centers for Disease Control and Prevention recently lowered the recommended age for Menactra, a vaccine given to protect against a form of meningitis Washington Post, Novartis Presents Full Pipeline Of Novel Vaccines Addressing ... - Jun 3, 2008 The co-primary objectives were lot-to-lot consistency for three Menveo lots and seroresponse non-inferiority of Menveo as compared with Menactra for the 11 ABN Newswire (press release), Report From the Advisory Committee on Immunization Practices (ACIP ... - Jun 24, 2008 1-3 On October 17, 2007, the Food and Drug Administration added approval for use of quadrivalent meningococcal conjugate vaccine (MCV4) (Menactra®, Journal of American Medical Association (subscription), US FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine ... - Jun 23, 2008 In 2005, sanofi pasteur continued its tradition of innovation by introducing Menactra(R)(f) vaccine to protect against meningococcal disease, Earthtimes (press release), Cabarrus Health This Week - Jun 22, 2008 Menactra (meningococcal vaccine) available for people ages 11-55. For adults, tetanus/diphtheria booster shots available; routine tetanus boosters Charlotte Observer, Get Tdap Vaccine to Assure School Enrollment - Jun 3, 2008 Other vaccines that are recommended for adolescents are Hepatitis A, Menactra (meningococcal meningitis) and Gardasil for girls (against Human WNCT, Syncope After Vaccination—United States, January 2005–July 2007 - Jun 3, 2008 Inc., Whitehouse Station, New Jersey) in a 3-dose series, the quadrivalent meningococcal conjugate vaccine (MCV4) (Menactra®, Sanofi Pasteur, Inc., Journal of American Medical Association (subscription), MCDH: Plan vaccine schedule for college, middle-schoolers - Jun 9, 2008 The vaccine for meningitis, known as Menactra, is routinely recommended for all 11- through 18-year-olds. Another vaccine to consider at the sixth-grade Northwest Herald, Blockbuster vaccine battle shaping up in meningococcal field - Jun 6, 2008 ...comparative trials and its four-dose approach to the infant market will help its candidate compete with Sanofi-Aventis' blockbuster Menactra. SmartBrief, Healthcare notes for June 10, 2008 - Jun 9, 2008 ...located on the St. Francis campus, 2016 S. Main St. Meningitis (Menactra), tetanus (Adacel) and HPV (Gardasil) vaccines will be available at that time. St. Joseph News-Press, Novartis Says Meningitis Vaccine Performed Well in Large Trial - May 6, 2008 Menveo is designed to protect against four types of meningitis bacteria: serotypes A, C, W-135 and Y. Sanofi's Menactra, launched in 2005, Wall Street Journal Menactra for Meningitis, Suicide and Genes, CDC Link Less Sleep to ... - May 8, 2008 In a randomized clinical trial evaluating the effects of Menactra on antibodies produced against meningitis, those who received the vaccine developed higher Insider Medicine, Novartis Vaccine Successful Against Meningitis in Phase III Trial - May 13, 2008 Novartis’ meningitis vaccine Menveo may offer greater protection for adolescents than sanofi pasteur’s Menactra based on results of a pivotal Phase III FDA news (subscription), ALSO NOTED: Vaccine benefits studied; Menveo wins head-to-head ... - May 8, 2008 Story Novartis has presented Phase III data that demonstrates Menveo is more effective than Sanofi Pasteur's Menactra in combating meningitis among FierceBioResearcher, Meningitis vaccine boosts immune response - May 7, 2008 ...to 18-year-olds showed Menveo helped trigger a strong immune response in a greater percentage of adolescents than the Sanofi-Aventis vaccine Menactra. Trading Markets (press release), Are Vaccines Made In China? - May 12, 2008 Infanrix (DTaP) - GlaxoSmithKline Biologicals, but manufactured by Chiron-Behring GmbH & Co. in Marburg, Germany Menactra (Meningococcal) - Sanofi Pasteur, About - News & Issues, Routine Vaccination With Meningococcal Conjugate Vaccine Not ... - May 5, 2008 The MCV4 (Menactra; Sanofi-Pasteur) was approved by the US Food and Drug Administration on October 17, 2007, for use in children aged 2 to 10 years, Medscape (subscription) Gardasil reactions on the rise - May 13, 2008 The physician noted that on 06-NOV-2007, the patient had been vaccinated with a dose of HAVRIX and a dose of MENACTRA. There was no illness at the time of renewamerica.us, Sudden infection kills Perry High School senior - 23 Apr 2008 The vaccine Menactra is available through the health department, and private physicians also may have Menomune, she said. According to the Web site of the Macon Telegraph, Perry High student dies of meningococcal disease - Apr 22, 2008 The vaccine menactra is available through the health department, and private physicians may also have menomune, she said. Macon Telegraph, Mumps: US assessing need for new vaccine - Apr 11, 2008 In the US, adolescents have indeed become a key target population for vaccination, with several new products such as the meningitis vaccine Menactra and the Pharmaceutical Business Review A Mother Whose Son Died From Meningitis Speaks Out - Mar 29, 2008 There are two vaccines that work against most strands of meningitis, Menactra and Menomune. The Centers for Disease Control advises that children start WLOX, National PUblic Health Week: Nursing Division is here to serve - Apr 9, 2008 As high school seniors are graduating this year, don't forget to obtain the Menactra vaccine to prevent bacterial meningitis when those students are away at Morris Daily Herald, A walk to remember - Apr 5, 2008 The US Food and Drug Administration has approved the Menactra vaccine for 11 to 55 year olds. The vaccine is 85 percent effective in covering four of the Gazette Online, CHS students, faculty cope with meningitis death - Mar 5, 2008 Students also can get the vaccine Menactra, which is available through local physicians and prevents all types of the meningococcal disease. Cody Enterprise, Campus officials getting word out on meningitis - Mar 1, 2008 Two licensed vaccines are available: Menomune, which has been available since 1981; and Menactra, licensed in 2005, which is considered longer-lasting. Urbana/Champaign News-Gazette, 2nd meningitis case not contagious - Mar 3, 2008 They should contact their children's physicians for details on Menactra, the recommended vaccine, Jamieson said. Jamieson is expected to release further Billings Gazette, Panel hesitates on expanding meningitis shots - Feb 27, 2008 A second Sanofi vaccine, called Menactra or meningococcal polysaccharide vaccine, is routinely recommended for adolescents and children 11 and older. Scientific American HEALTH: Meningitis for all - Mar 5, 2008 NeisVac-C, Menjugate and Meningitec vaccines protect against bacterial strain C. Menactra and Menomune vaccines protect against strains A, C, McGill Tribune (subscription), Cody meningitis cases share no links, official says - Mar 3, 2008 ...avoid meningitis, he said, adding that parents of children ages 12 to 18 should contact their family doctors for information on Menactra, the vaccine. Billings Gazette, Cabarrus Health This Week - Mar 2, 2008 Menactra (meningococcal vaccine) available for people ages 11-55. For adults, tetanus/diphtheria booster shots available; routine tetanus boosters Charlotte Observer, Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp ... - Feb 12, 2008 An extension to the license for Menactra(R), covering children aged 2 to 10, was obtained in the United States in October 2007. Over the full year, PR Newswire (press release), Meningitis: a rare but dangerous disease for students - Feb 27, 2008 Hall Health has Menactra, a vaccine available since 2005, which protects against the disease for up to 10 years, Haulman said. Another vaccine, Menomune Daily - University of Washington, 2nd case of meningitis reported in Tehama County. - Feb 27, 2008 The meningococcal vaccine currently licensed for use in the US, whose trade name is Menactra®, protects against four of the five major meningococcal Red Bluff Daily News, Health Dept. boosts fees for shots - Feb 26, 2008 College students can get meningococcal menactra, a shot for bacterial meningitis. A treatment of Gardasil is $130. Gardasil is a treatment for genital warts Pratt Tribune, Student Dies Of Suspected Meningitis - Feb 14, 2008 Friday to answer parent's questions. Medical experts said there is a vaccine available that protects you against some strains of meningitis called Menactra. NewsChannel5.com, Love is in the air at PC North - 06 Feb 2008 18 to provide seniors with immunizations, including the menactra-meningitis shot that many Oklahoma colleges require. The service is free, so make sure you Oklahoma City Friday, Study shows new 4-strain meningitis vaccine safe, effective in infants - Jan 8, 2008 Based on that and other concerns, the National Advisory Committee on Immunization recommended against another new four-strain vaccine last year, Menactra. The Canadian Press Novartis Vaccine Shows Promise - Jan 8, 2008 Menveo would compete against Sanofi-Aventis SA's Menactra. The Novartis product is the first four-strain conjugated meningitis vaccine to generate Wall Street Journal Novartis’ Menveo against Meningitis Has Positive Results in Infants - Jan 9, 2008 The new vaccine will compete with Sanofi-Aventis SA’s Menactra, a similar vaccine against meningitis, which has shown immune responses in children aged 2-10 eFluxMedia Meningitis Drug For Infants on the Horizon - Jan 9, 2008 In October, a competitor, Sanofi-Aventis won FDA approval for a similar vaccine, called Menactra, to be used in children ages two to ten. InjuryBoard.com, Novartis' Menveo is first quadrivalent meningococcal vaccine - Jan 9, 2008 ...no currently available quadrivalent vaccine including Sanofi Pasteur’s Menomune and Menactra “has demonstrated a strong and lasting immune response�. Pharma Times (subscription), Vaccines get a boost: Global market increases profitability of ... - Jan 27, 2008 The process was developed in the 1980s but is paying off now with such vaccines as Prevnar and the meningococcal conjugate vaccine, Menactra, American Medical News (subscription) Craig briefs for Jan. 24 - Jan 23, 2008 It is now recommended that all adolescents ages 11 to 18 receive the Menactra vaccine, to protect against Meningitis, at the earliest possible health care Craig Daily Press, Meningitis shot boosts immunity in infants: study - Jan 8, 2008 ...to make regulatory submissions in 2008. Sanofi-Aventis in October won US regulatory approval for a similar vaccine called Menactra for children aged 2-10. Scientific American A mother wonders whether the sudden death of her 19-year-old ... - Jan 23, 2008 NVIC found that reports of Guillain-Barre were 10 times higher when Menactra and Gardasil were given together. �Both of my daughters received the Gardasil Metro Spirit, New Data Show Menveo(TM) To Be The First Quadrivalent ... - Jan 16, 2008 However, no currently available quadrivalent vaccine including Menomune [1] and Menactra [2] has demonstrated a strong and lasting immune response for this Medical News Today (press release), Cabarrus Health This Week - Jan 13, 2008 Menactra (meningococcal vaccine) available for people ages 11-55. For adults, tetanus/diphtheria booster shots available; routine tetanus boosters Charlotte Observer, Kids', Teens' Shots Recs Updated - Jan 11, 2008 ...involves the quadrivalent meningococcal conjugate vaccine, or MCV4, which is manufactured by sanofi pasteur of Swiftwater, Pa., and sold as Menactra. AAFP News Now Health department to offer vaccine at Minooka HS - Jan 11, 2008 MINOOKA - The Grundy County Health Department will offer the Menactra vaccine to Minooka Community High School seniors on Thursday, Feb. Morris Daily Herald, JAMA article boosts Novartis meningitis jab - Jan 10, 2008 The product is likely to compete directly with Sanofi Pasteur's quadrivalent vaccines Menactra and Menomune, both of which protect against the same 4 In-PharmaTechnologist.com, Novartis' new meningitis vaccine appears safe for infants - Jan 9, 2008 ...it would compete against Sanofi-Aventis’ similar vaccine called Menactra, which was approved by the US regulators in October for children aged 2-10. The Money Times, New meningitis vaccine a potential new weapon against the deadly ... - Jan 9, 2008 Last October another drug company, Sanofi-Aventis was awarded US regulatory approval for a similar vaccine called Menactra for children aged 2-10. News-Medical.net, At-Risk Children Get New Meningococcal Vaccine - Dec 11, 2007 The vaccine, known as Menactra, received approval by the US Food and Drug Administration (FDA) this past October for use in young children. MedHeadlines, ACIP Issues New Meningococcal Vaccine Recommendations - Dec 7, 2007 7- For children ages two to 10 at risk for invasive meningococcal disease, the quadrivalent conjugate vaccine (Menactra) is preferable to the polysaccharide MedPage Today, Daily News: Bacterial Meningitis Vaccine OK'd - Nov 24, 2007 The bacterial meningitis vaccine Menactra, approved for people ages 11 to 55 in 2005, additionally has been approved for children ages 2 to 10, Nurse.com, USF to mass vaccinate students against - Nov 28, 2007 Starting in January, all USF students new to campus residences must receive the vaccine, Menactra. It's the most stringent vaccination policy of any Florida ABC Action News, 2007 - Another bumper year for top vaccine companies - Dec 12, 2007 ...against rotavirus induced gastroenteritis contributing $375m up to Q3 2007 and Sanofi’s meningitis vaccine, Menactra contributing $471m. PharmiWeb.com (press release), Recommendations updated for PCV7, MCV4 vaccines - Nov 30, 2007 The Food and Drug Administration expanded the licensed age range for quadrivalent meningococcal conjugate vaccine (MCV4, Menactra, sanofi pasteur) on Oct. AAP News (subscription) USF plans for shots against disease - Nov 28, 2007 Starting in January, all USF students new to campus residence halls must receive the vaccine, Menactra, which protects against a disease that killed one of Sarasota Herald-Tribune, : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |